Evaluation of hematological parameters as an indicator of disease severity in Covid‐19 patients: Pakistan's experience

202161 citationsJournal Articlegold Open Access

Authors

Abdul Waris · Quaid-i-Azam University

Misbahud Din · Quaid-i-Azam University

Atiqa Khalid · University of Health Sciences Lahore

Raees Abbas Lail · University of Health Sciences Lahore

Asmat Shaheen · Kohat University of Science and Technology

Nida Jamil Khan · Hayatabad Medical Complex

Mehboob Nawaz

Abstract

These blood parameters could be used as a suitable biomarker for the prognosis and severity of COVID-19. Evaluating novel hemograms NLR, PLR, and LMR can aid clinicians to identify potentially severe cases at early stages, initiate effective management in time, and conduct early triage which may reduce the overall mortality of COVID-19 patients.

Topics & Keywords

COVID-19 Clinical Research Studies Inflammatory Biomarkers in Disease Prognosis COVID-19 Impact on Reproduction

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Laboratory Analysis

Volume 35, Issue 6, pp. e23809-e23809

DOI: 10.1002/jcla.23809

Field-Weighted Citation Impact: 3.64